Posts tagged as:
Author
FDA's First “Program” Reviews: Fast Approvals, But Still Some …
by admin on September 25, 2013
Drug Spending Expected To Rise By $200 Bil. In 2022 Compared …
by admin on September 24, 2013
FDA “Data Steward” Role Suggested By Industry In Lieu of Direct …
by admin on September 10, 2013
FDA “Data Steward” Role Suggested By Industry In Lieu of Direct …
by admin on September 10, 2013
The RPM Report – Elsevier Business Intelligence
by admin on August 14, 2013
FDA's “Breakthrough” Exceeds Expectations; Will It Break The Bank …
by admin on August 9, 2013
FDA's “Breakthrough” Exceeds Expectations; Will It Break The Bank …
by admin on August 9, 2013
The Value of Knowing: CMS Rejects Coverage of Lilly's Amyvid …
by admin on July 24, 2013
FDA Quality Profiling: Agency Hopes to Channel Corporate Attention …
by admin on July 19, 2013
Structured Risk-Benefit Framework Strikes Back: FDA Suvorexant …
by admin on July 1, 2013